Yu Ko

2.5k total citations
86 papers, 1.8k citations indexed

About

Yu Ko is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yu Ko has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Geriatrics and Gerontology, 20 papers in Economics and Econometrics and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yu Ko's work include Pharmaceutical Practices and Patient Outcomes (23 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Diabetes Management and Education (8 papers). Yu Ko is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (23 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Diabetes Management and Education (8 papers). Yu Ko collaborates with scholars based in Taiwan, Singapore and United States. Yu Ko's co-authors include Ye Wang, Morgan Bron, Daniel C. Malone, Jia Wen Nicole Lee, Alexandre Chan, Stephen Joel Coons, Raymond L. Woosley, Ming Kong, Grant H. Skrepnek and Edward P. Armstrong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yu Ko

80 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Ko Taiwan 27 446 352 297 286 278 86 1.8k
Wendy L. St. Peter United States 35 364 0.8× 262 0.7× 214 0.7× 368 1.3× 370 1.3× 105 3.7k
Jennifer M. Polinski United States 29 331 0.7× 216 0.6× 224 0.8× 293 1.0× 698 2.5× 72 2.6k
Diana Brixner United States 29 208 0.5× 329 0.9× 348 1.2× 326 1.1× 497 1.8× 174 2.7k
Grant H. Skrepnek United States 24 333 0.7× 281 0.8× 209 0.7× 222 0.8× 271 1.0× 97 1.9k
Alex Z. Fu United States 29 312 0.7× 1.0k 2.9× 295 1.0× 504 1.8× 566 2.0× 117 3.1k
Maribel Salas United States 20 290 0.7× 218 0.6× 134 0.5× 194 0.7× 295 1.1× 74 2.9k
Ilkka Kunnamo Finland 26 285 0.6× 132 0.4× 312 1.1× 466 1.6× 260 0.9× 77 2.1k
Jan D. Hirsch United States 25 710 1.6× 111 0.3× 182 0.6× 706 2.5× 254 0.9× 67 2.3k
David P. Nau United States 18 508 1.1× 374 1.1× 183 0.6× 112 0.4× 375 1.3× 49 2.0k
P. Ricordeau France 26 198 0.4× 332 0.9× 489 1.6× 386 1.3× 276 1.0× 69 2.4k

Countries citing papers authored by Yu Ko

Since Specialization
Citations

This map shows the geographic impact of Yu Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Ko more than expected).

Fields of papers citing papers by Yu Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Ko. The network helps show where Yu Ko may publish in the future.

Co-authorship network of co-authors of Yu Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Ko. A scholar is included among the top collaborators of Yu Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Ko. Yu Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Yi-Wen, et al.. (2023). Health Utilities of Bilateral Severe-to-Profound Hearing Loss with Assistive Devices. Healthcare. 11(11). 1649–1649. 2 indexed citations
3.
Wang, Hsian-Jenn, et al.. (2022). Effectiveness of Botulinum Toxin Type A Injection on Scars: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Plastic & Reconstructive Surgery. 150(6). 1249e–1258e. 2 indexed citations
4.
5.
Chen, Yen‐Chou, et al.. (2021). Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk. Scientific Reports. 11(1). 1430–1430. 8 indexed citations
6.
7.
Lau, Tang Ching, et al.. (2017). Cost of Osteoporotic Fractures in Singapore. Value in Health Regional Issues. 12. 27–35. 6 indexed citations
8.
Lee, Bora, et al.. (2016). Effects of 12-week Vegetarian Diet on the Nutritional Status, Stress Status and Bowel Habits in Middle School Students and Teachers. Clinical Nutrition Research. 5(2). 102–102. 6 indexed citations
9.
Ko, Yu, et al.. (2014). Cost-of-illness studies of diabetes mellitus: A systematic review. Diabetes Research and Clinical Practice. 105(2). 151–163. 96 indexed citations
10.
Xie, Feng, et al.. (2014). Assessment of Preference for Hormonal Treatment–Related Health States among Patients with Breast Cancer. Value in Health Regional Issues. 3. 27–32. 7 indexed citations
11.
Wang, Ye, Ming Kong, & Yu Ko. (2013). Comparison of three medication adherence measures in patients taking warfarin. Journal of Thrombosis and Thrombolysis. 36(4). 416–421. 24 indexed citations
12.
Kim, Song‐Yi, Younbyoung Chae, Hyangsook Lee, et al.. (2012). Study for Clinicians' Perception on the Acupuncture Research and Ways to Symbiosis between Basic Research and Clinical Practice. Korean Journal of Acupuncture. 29(2). 224–238. 2 indexed citations
13.
Lee, Jia Wen Nicole, et al.. (2012). Validity and reliability of a self‐reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore. Diabetic Medicine. 29(9). e338–44. 40 indexed citations
14.
Lee, Jia Wen Nicole, et al.. (2012). Health‐related quality of life and glycaemic control in patients with Type 2 diabetes mellitus in Singapore. Diabetic Medicine. 29(8). e241–8. 80 indexed citations
15.
Shih, Vivianne, Alexandre Chan, Feng Xie, & Yu Ko. (2012). Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore. Value in Health Regional Issues. 1(1). 46–53. 7 indexed citations
16.
Wang, Ye, Ming Kong, & Yu Ko. (2012). Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. Thrombosis and Haemostasis. 108(10). 789–795. 41 indexed citations
17.
Grizzle, Amy J., Yu Ko, John E. Murphy, et al.. (2007). Reasons provided by prescribers when overriding drug-drug interaction alerts.. PubMed. 13(10). 573–8. 70 indexed citations
18.
Ko, Yu & Stephen Joel Coons. (2006). Self-reported chronic conditions and EQ‐5D index scores in the US adult population. Current Medical Research and Opinion. 22(10). 2065–2071. 48 indexed citations
19.
Ko, Yu, et al.. (2006). Brief Report: Development of a prescription medication information webliography for consumers. Journal of General Internal Medicine. 21(12). 1313–1316. 10 indexed citations
20.
Ko, Yu, et al.. (2005). The impact of urinary incontinence on quality of life of the elderly.. PubMed. 11(4 Suppl). S103–11. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy L. St. Peter Breakdown of academic impact, for papers by Jennifer M. Polinski Breakdown of academic impact, for papers by Diana Brixner Breakdown of academic impact, for papers by Grant H. Skrepnek Breakdown of academic impact, for papers by Alex Z. Fu Breakdown of academic impact, for papers by Maribel Salas Breakdown of academic impact, for papers by Ilkka Kunnamo Breakdown of academic impact, for papers by Jan D. Hirsch Breakdown of academic impact, for papers by David P. Nau Breakdown of academic impact, for papers by P. Ricordeau
Rankless by CCL
2026